A mechanistic model of tau amyloid aggregation based on direct observation of oligomers

Sarah L. Shammas, Gonzalo A. Garcia, Satish Kumar, Magnus Kjaergaard, Mathew H. Horrocks, Nadia Shivji, Eva Mandelkow, Tuomas P.j. Knowles, Eckhard Mandelkow, David Klenerman

Research output: Contribution to journalArticlepeer-review


Protein aggregation plays a key role in neurodegenerative disease, giving rise to small oligomers that may become cytotoxic to cells. The fundamental microscopic reactions taking place during aggregation, and their rate constants, have been difficult to determine due to lack of suitable methods to identify and follow the low concentration of oligomers over time. Here we use single-molecule fluorescence to study the aggregation of the repeat domain of tau (K18), and two mutant forms linked with familial frontotemporal dementia, the deletion mutant ΔK280 and the point mutant P301L. Our kinetic analysis reveals that aggregation proceeds via monomeric assembly into small oligomers, and a subsequent slow structural conversion step before fibril formation. Using this approach, we have been able to quantitatively determine how these mutations alter the aggregation energy landscape.
Original languageEnglish
Article number7025
Number of pages10
JournalNature Communications
Early online date30 Apr 2015
Publication statusPublished - 30 Apr 2015


Dive into the research topics of 'A mechanistic model of tau amyloid aggregation based on direct observation of oligomers'. Together they form a unique fingerprint.

Cite this